PRODUCTS

Arena Life Science

Ranolaze®

  • Generic name: Ranolazine

  • Pharmacologic Category: Anti-anginal

  • Dosage Forms: 500 mg extended-release tablet

  • Mechanism of Action: A direct, selective inhibitor of Factor Xa 

  • Treatment of chronic/refractory angina with no effect on heart rate and blood pressure.

Description:

Ranolazine acts by inhibiting the cardiac late sodium current (INa) and
hence prevents sodium dependent calcium accumulation in the cell.

It is important to know, 25-30% of patients with coronary artery disease have
persistent angina pectoris despite of PCI with or without optimal medical therapy

Product images
  • Ranolazine (Ranplaze 500)
Product sharing
Related products

Company Address

No 20, 5th Floor , 8th Sharestan , Makoueipour St, Za'feraniyeh, Tehran-Iran

Phone: (+98) 21 26 80 2107 - Fax: (+98) 21 26 80 2107     Email: info@arenalifescience.com

DNN